Institute seminar Wedesday Nov 2nd
Erlend B. Smeland
The institute seminar on Wednesday, 23rd of November 11:30 a.m. will be held by Erlend B. Smeland. He will present information from the institute council. The seminar will be in Norwegian.
From major journals, first or last author from the Institute for Cancer Research
Unal B, Saatcioglu F(2025) Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppression Biomark Res, 13(1), 156 DOI 10.1186/s40364-025-00813-y, PubMed 41372991
Pinto R, Sjurgard IV, Pharo H, Mala T, Vedeld HM, Lind GE(2025) Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategy Oncogene(in press) DOI 10.1038/s41388-025-03650-3, PubMed 41361079
Lapão A, Johnson LS, Trachsel-Moncho L, Rodgers SJ, Singh S, Ng MYW, Nakken S, Eskelinen EL, Simonsen A(2025) The RAB27A effector SYTL5 regulates mitophagy and mitochondrial metabolism Elife, 14 DOI 10.7554/eLife.105541, PubMed 41294009
Emaldi M, Rey-Iborra E, Alamillo-Maeso P, Pulido R, Nunes-Xavier CE(2026) Analysis of the Functional Impact of Glycosylation on Immune Checkpoint Proteins Methods Mol Biol, 2959, 55-72 DOI 10.1007/978-1-0716-4734-9_4, PubMed 41028258
Pharo H, Brandt-Winge S, Thorkildsen EM, Vedeld HM, Lind GE(2026) DNA Methylation Analyses of Tissue Samples and Cell-Free DNA by Droplet Digital PCR Methods Mol Biol, 2969, 179-193 DOI 10.1007/978-1-0716-4767-7_12, PubMed 41073866
Rey-Iborra E, Emaldi M, Madariaga M, Pulido R, Nunes-Xavier CE(2026) 3D Spheroids to Study the Impact of Immune Checkpoint Proteins in Solid Tumors Methods Mol Biol, 2959, 141-156 DOI 10.1007/978-1-0716-4734-9_10, PubMed 41028264
